{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:37:36Z","timestamp":1790699856438,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04657-z","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:40:18Z","timestamp":1759999218000},"page":"3771-3783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing the disease burden of opioid use disorder in western europe: trends, gender differences, and future directions"],"prefix":"10.1007","volume":"399","author":[{"given":"Dingwen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"2","key":"4657_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5114\/ait.2020.94756","volume":"52","author":"K Ayoo","year":"2020","unstructured":"Ayoo K, Mikhaeil J, Huang A, W\u0105sowicz M (2020) The opioid crisis in North America: facts and future lessons for Europe. Anaesthesiol Intensive Ther 52(2):139\u2013147. https:\/\/doi.org\/10.5114\/ait.2020.94756","journal-title":"Anaesthesiol Intensive Ther"},{"issue":"12","key":"4657_CR2","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1097\/jxx.0000000000000801","volume":"34","author":"SL Baumann","year":"2022","unstructured":"Baumann SL, Samuels WE (2022) Comorbidities in older adults with opioid use disorders. J Am Assoc Nurse Pract 34(12):1280\u20131288. https:\/\/doi.org\/10.1097\/jxx.0000000000000801","journal-title":"J Am Assoc Nurse Pract"},{"issue":"1","key":"4657_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/10550887.2022.2067463","volume":"41","author":"F Castillo","year":"2023","unstructured":"Castillo F, Scalise D, Hernandez D, Gupta R, Basaraba CN, Corbeil T et al (2023) Preliminary attitudes on medications for opioid use disorders (MOUDs) in southeastern Switzerland and New York City. J Addict Dis 41(1):91\u201397. https:\/\/doi.org\/10.1080\/10550887.2022.2067463","journal-title":"J Addict Dis"},{"key":"4657_CR4","doi-asserted-by":"publisher","unstructured":"Chenaf C, Kabor\u00e9 JL, Delorme J, Pereira B, Mulliez A, Zenut M et al (2019) Prescription opioid analgesic use in France: Trends and impact on morbidity-mortality. Eur J Pain 23(1):124\u201334. https:\/\/doi.org\/10.1002\/ejp.1291","DOI":"10.1002\/ejp.1291"},{"issue":"10","key":"4657_CR5","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/s1474-4422(24)00369-7","volume":"23","author":"Collaborators GSRF","year":"2024","unstructured":"Collaborators GSRF (2024) Global, regional, and national burden of stroke and its risk factors, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23(10):973\u20131003. https:\/\/doi.org\/10.1016\/s1474-4422(24)00369-7","journal-title":"Lancet Neurol"},{"issue":"10208","key":"4657_CR6","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/s0140-6736(19)32229-9","volume":"394","author":"L Degenhardt","year":"2019","unstructured":"Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL et al (2019) Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet 394(10208):1560\u20131579. https:\/\/doi.org\/10.1016\/s0140-6736(19)32229-9","journal-title":"Lancet"},{"key":"4657_CR7","doi-asserted-by":"publisher","unstructured":"Fang M, Zhang Q, Peng J, Yao W, Feng W, Wan X (2025) Global, regional, and national burden of opioid use disorder from 1990 to 2021: a statistical analysis of incidence, mortality, and disability-adjusted life years. BMC Public Health 25(1):1988. https:\/\/doi.org\/10.1186\/s12889-025-23283-1","DOI":"10.1186\/s12889-025-23283-1"},{"issue":"2","key":"4657_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1360-0443.2011.03369.x","volume":"107","author":"P Griffiths","year":"2012","unstructured":"Griffiths P, Mounteney J, Lopez D, Zobel F, G\u00f6tz W (2012) Addiction research centres and the nurturing of creativity. Monitoring the European drug situation: the ongoing challenge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Addiction 107(2):254\u2013258. https:\/\/doi.org\/10.1111\/j.1360-0443.2011.03369.x","journal-title":"Addiction"},{"key":"4657_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.drugpo.2018.01.021","volume":"56","author":"T Groshkova","year":"2018","unstructured":"Groshkova T, Cunningham A, Royuela L, Singleton N, Saggers T, Sedefov R (2018) Drug affordability-potential tool for comparing illicit drug markets. Int J Drug Policy 56:187\u2013196. https:\/\/doi.org\/10.1016\/j.drugpo.2018.01.021","journal-title":"Int J Drug Policy"},{"issue":"8","key":"4657_CR10","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/ejp.1786","volume":"25","author":"W H\u00e4user","year":"2021","unstructured":"H\u00e4user W, Buchser E, Finn DP, Dom G, Fors E, Heiskanen T et al (2021) Is Europe also facing an opioid crisis?\u2014A survey of European Pain Federation chapters. Eur J Pain 25(8):1760\u20131769. https:\/\/doi.org\/10.1002\/ejp.1786","journal-title":"Eur J Pain"},{"key":"4657_CR11","doi-asserted-by":"publisher","unstructured":"Jenkins RA (2021) The fourth wave of the US opioid epidemic and its implications for the rural US: A federal perspective. Prev Med 152(Pt 2):106541. https:\/\/doi.org\/10.1016\/j.ypmed.2021.106541","DOI":"10.1016\/j.ypmed.2021.106541"},{"issue":"8","key":"4657_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/s2215-0366(19)30209-3","volume":"6","author":"J Kimber","year":"2019","unstructured":"Kimber J, Hickman M, Strang J, Thomas K, Hutchinson S (2019) Rising opioid-related deaths in England and Scotland must be recognised as a public health crisis. Lancet Psychiatr 6(8):639\u2013640. https:\/\/doi.org\/10.1016\/s2215-0366(19)30209-3","journal-title":"Lancet Psychiatr"},{"key":"4657_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.forsciint.2018.05.042","volume":"289","author":"K Kuczy\u0144ska","year":"2018","unstructured":"Kuczy\u0144ska K, Grzonkowski P, Kacprzak \u0141, Zawilska JB (2018) Abuse of fentanyl: an emerging problem to face. Forensic Sci Int 289:207\u2013214. https:\/\/doi.org\/10.1016\/j.forsciint.2018.05.042","journal-title":"Forensic Sci Int"},{"key":"4657_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.gerinurse.2022.05.002","volume":"46","author":"M Mackiewicz","year":"2022","unstructured":"Mackiewicz M, Brown RE, Price ET, Sargent L (2022) Quality of life in older adults with opioid use disorder: a scoping review. Geriatr Nurs 46:118\u2013124. https:\/\/doi.org\/10.1016\/j.gerinurse.2022.05.002","journal-title":"Geriatr Nurs"},{"key":"4657_CR15","doi-asserted-by":"publisher","unstructured":"Nowakowska M, Zghebi SS, Chen LC, Ashcroft DM, Kontopantelis E (2023) Examining non-linearity in the association between age and reported opioid use in different socioeconomic strata: cohort study using Health Survey for England waves from 1997 to 2014. BMJ Open 13(3):e057428. https:\/\/doi.org\/10.1136\/bmjopen-2021-057428","DOI":"10.1136\/bmjopen-2021-057428"},{"key":"4657_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.drugpo.2018.02.005","volume":"55","author":"M Pierce","year":"2018","unstructured":"Pierce M, Millar T, Robertson JR, Bird SM (2018) Ageing opioid users\u2019 increased risk of methadone-specific death in the UK. Int J Drug Policy 55:121\u2013127. https:\/\/doi.org\/10.1016\/j.drugpo.2018.02.005","journal-title":"Int J Drug Policy"},{"issue":"1","key":"4657_CR17","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2021.2219","volume":"64","author":"M Pierce","year":"2021","unstructured":"Pierce M, van Amsterdam J, Kalkman GA, Schellekens A, van den Brink W (2021) Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018. Eur Psychiatry 64(1):e47. https:\/\/doi.org\/10.1192\/j.eurpsy.2021.2219","journal-title":"Eur Psychiatry"},{"key":"4657_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s13670-025-00431-4","author":"JD Pytell","year":"2025","unstructured":"Pytell JD, Robertson ML, Han BH, Martinez NG (2025) Opioid use disorder in older adults: a narrative review. Curr Geriatr Rep. https:\/\/doi.org\/10.1007\/s13670-025-00431-4","journal-title":"Curr Geriatr Rep"},{"key":"4657_CR19","doi-asserted-by":"publisher","unstructured":"Roberts E, Doidge JC, Harron KL, Hotopf M, Knight J, White M et al (2020) National administrative record linkage between specialist community drug and alcohol treatment data (the National Drug Treatment Monitoring System (NDTMS)) and inpatient hospitalisation data (Hospital Episode Statistics (HES)) in England: design, method and evaluation. BMJ Open 10(11):e043540. https:\/\/doi.org\/10.1136\/bmjopen-2020-043540","DOI":"10.1136\/bmjopen-2020-043540"},{"issue":"6","key":"4657_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.70040","volume":"136","author":"PJ Samuelsen","year":"2025","unstructured":"Samuelsen PJ, Hjellvik V, Odsbu I, Stubhaug A, Skurtveit S, Vambheim SM (2025) Trends in postoperative opioid use in Norway 2011\u20132018: a nationwide registry-based study. Basic Clin Pharmacol Toxicol 136(6):e70040. https:\/\/doi.org\/10.1111\/bcpt.70040","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"4657_CR21","doi-asserted-by":"publisher","unstructured":"Schaffer AL, Dobbins TA, Pearson SA (2021) Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions. BMC Med Res Methodol 21(1):58. https:\/\/doi.org\/10.1186\/s12874-021-01235-8","DOI":"10.1186\/s12874-021-01235-8"},{"issue":"2","key":"4657_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1089\/jwh.2020.8610","volume":"31","author":"M Serdarevic","year":"2022","unstructured":"Serdarevic M, Osborne V, Striley CW, Cottler LB (2022) Prescription opioid use among a community sample of older and younger women. J Womens Health 31(2):270\u2013278. https:\/\/doi.org\/10.1089\/jwh.2020.8610","journal-title":"J Womens Health"},{"issue":"5","key":"4657_CR23","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/ejp.1728","volume":"25","author":"T Seyler","year":"2021","unstructured":"Seyler T, Giraudon I, Noor A, Mounteney J, Griffiths P (2021) Is Europe facing an opioid epidemic: What does European monitoring data tell us? Eur J Pain 25(5):1072\u20131080. https:\/\/doi.org\/10.1002\/ejp.1728","journal-title":"Eur J Pain"},{"issue":"4","key":"4657_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/aas.12281","volume":"58","author":"K Svendsen","year":"2014","unstructured":"Svendsen K, Fredheim OM, Romundstad P, Borchgrevink PC, Skurtveit S (2014) Persistent opioid use and socio-economic factors: a population-based study in Norway. Acta Anaesthesiol Scand 58(4):437\u2013445. https:\/\/doi.org\/10.1111\/aas.12281","journal-title":"Acta Anaesthesiol Scand"},{"key":"4657_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.euroneuro.2021.09.002","volume":"54","author":"M Torrens","year":"2022","unstructured":"Torrens M, Fonseca F (2022) Opioid use and misuse in Europe: COVID-19 new challenges? Eur Neuropsychopharmacol 54:67\u201369. https:\/\/doi.org\/10.1016\/j.euroneuro.2021.09.002","journal-title":"Eur Neuropsychopharmacol"},{"key":"4657_CR26","doi-asserted-by":"publisher","unstructured":"Trakakis A, Theocharis A, Prezerakos P (2025) Evaluating the efficiency and productivity of opioid substitution treatment units in Greece: a DEA-malmquist analysis. Healthcare\u00a013(8).\u00a0https:\/\/doi.org\/10.3390\/healthcare13080943","DOI":"10.3390\/healthcare13080943"},{"issue":"3","key":"4657_CR27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1183\/13993003.01967-2015","volume":"48","author":"NT Vozoris","year":"2016","unstructured":"Vozoris NT, Wang X, Fischer HD, Bell CM, O\u2019Donnell DE, Austin PC et al (2016) Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J 48(3):683\u2013693. https:\/\/doi.org\/10.1183\/13993003.01967-2015","journal-title":"Eur Respir J"},{"issue":"6","key":"4657_CR28","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/add.13755","volume":"112","author":"MJM Vranken","year":"2017","unstructured":"Vranken MJM, Mantel-Teeuwisse AK, J\u00fcnger S, Radbruch L, Scholten W, Lisman JA et al (2017) Barriers to access to opioid medicines for patients with opioid dependence: a review of legislation and regulations in eleven central and eastern European countries. Addiction 112(6):1069\u20131076. https:\/\/doi.org\/10.1111\/add.13755","journal-title":"Addiction"},{"key":"4657_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100842","volume":"38","author":"HA Wafa","year":"2024","unstructured":"Wafa HA, Marshall I, Wolfe CDA, Xie W, Johnson CO, Veltkamp R et al (2024) Burden of intracerebral haemorrhage in Europe: forecasting incidence and mortality between 2019 and 2050. Lancet Reg Health 38:100842. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100842","journal-title":"Lancet Reg Health"},{"issue":"1","key":"4657_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-23476-8","volume":"25","author":"YF Zhang","year":"2025","unstructured":"Zhang YF, Ji YH, Hou HZ, Fan XZ, Yang B, Yao Z et al (2025) Burden of kidney cancer in China from 1990 to 2021 and predictions for 2036: an age-period-cohort analysis of global burden of disease study 2021. BMC Public Health 25(1):2211. https:\/\/doi.org\/10.1186\/s12889-025-23476-8","journal-title":"BMC Public Health"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04657-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04657-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04657-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:59:19Z","timestamp":1772006359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04657-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4657"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04657-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}